Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 1090 | 1035 | 1156 | 1132 | 1608 | 1937 |
| Fund Return | 8.99% | 3.48% | 15.61% | 4.23% | 9.97% | 6.83% |
| Place in category | 62 | 43 | 43 | 79 | 73 | 34 |
| % in Category | 46 | 35 | 41 | 65 | 68 | 48 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Rydex NASDAQ-100 Inv | 1.68B | -1.25 | 26.92 | 19.04 | ||
| Rydex Variable NASDAQ 100 2x Strate | 124.22M | -3.44 | 27.04 | 26.20 | ||
| Rydex Variable NASDAQ 100 | 106.01M | 2.10 | 11.82 | 16.98 | ||
| Rydex S&P 500 H | 126.88M | 1.30 | 19.11 | 13.62 | ||
| Rydex Biotechnology Inv | 109.32M | 2.11 | 11.18 | 8.68 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| T. Rowe Price New Era I | 1.91B | 20.64 | 15.23 | 10.69 | ||
| Vanguard Materials Index Adm | 1.52B | 17.63 | 12.28 | 12.47 | ||
| Aegis Value | 1.23B | 19.37 | 31.86 | 24.56 | ||
| T. Rowe Price New Era | 1.28B | 20.58 | 15.00 | 10.51 | ||
| GMO Resources IV | 1.26B | 21.99 | 6.34 | 14.30 |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| Linde PLC | IE000S9YS762 | 4.39 | 418.400 | +1.31% | |
| Sherwin-Williams | US8243481061 | 2.70 | 315.96 | +0.64% | |
| Air Products | US0091581068 | 2.67 | 287.14 | +3.04% | |
| CRH | IE0001827041 | 2.53 | 8,004.0 | +2.93% | |
| Freeport-McMoran | US35671D8570 | 2.46 | 56.25 | +2.38% |
| Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Buy |
| Technical Indicators | Strong Sell | Sell | Strong Buy |
| Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review